
Daiichi Sankyo inks $183M discovery deal with GPCR biotech for CNS target
Belgian biotech Confo Therapeutics has landed $183 million, plus potential royalties, in a drug-discovery deal with Daiichi Sankyo. Early Thursday, Confo Therapeutics put out word of the deal that will be focused on small molecule […]